Avoid common mistakes on your manuscript.
Correction to: Drugs & Therapy Perspectives (2022) 38:177–184 https://doi.org/10.1007/s40267-022-00905-x
The author has alerted us to the following error, and the following correction should be noted:
Page 178, column 2, ‘Method’ section, paragraph 2, lines 1–3: The text that previously read:
‘The study testing was performed during May 2020 at the ICU Medical, Inc, an FDA registered analytical laboratory (San Clemente, CA, USA).’
should read:
‘The study testing was performed during May 2020 at the ICU Medical, Inc, analytical laboratory (San Clemente, CA, USA).’
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Szkiladz, A., Hegner, S. Correction to: Evaluation of three barrier-type closed system transfer devices using the 2015 NIOSH vapor containment performance draft protocol. Drugs Ther Perspect 38, 292 (2022). https://doi.org/10.1007/s40267-022-00923-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-022-00923-9